Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Antitumor activity of an engineered decoy receptor targeting CLCF1–CNTFR signaling in lung adenocarcinoma
Jun W. Kim, César Márquez, Kaja Kostyrko, et al.
Nature Medicine (2019) Vol. 25, Iss. 11, pp. 1783-1795
Open Access | Times Cited: 55

Showing 1-25 of 55 citing articles:

Engineered ACE2 receptor therapy overcomes mutational escape of SARS-CoV-2
Yusuke Higuchi, Tatsuya Suzuki, Takao Arimori, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 122
Emerging roles for the IL-6 family of cytokines in pancreatic cancer
Gemma van Duijneveldt, Michael D. W. Griffin, Tracy L. Putoczki
Clinical Science (2020) Vol. 134, Iss. 16, pp. 2091-2115
Open Access | Times Cited: 85
The miR-30a-5p/CLCF1 axis regulates sorafenib resistance and aerobic glycolysis in hepatocellular carcinoma
Zhongqiang Zhang, Xiao Tan, Jing Luo, et al.
Cell Death and Disease (2020) Vol. 11, Iss. 10
Open Access | Times Cited: 76
RNA-based therapies: A cog in the wheel of lung cancer defense
Parvez Κhan, Jawed A. Siddiqui, Imayavaramban Lakshmanan, et al.
Molecular Cancer (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 73
CLCF1 signaling restrains thermogenesis and disrupts metabolic homeostasis by inhibiting mitochondrial biogenesis in brown adipocytes
Meng Ding, Hongyu Xu, Wei-Yu Zhou, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 33
Open Access | Times Cited: 14
Spatially resolved analysis of pancreatic cancer identifies therapy-associated remodeling of the tumor microenvironment
Carina Shiau, Jingyi Cao, Dennis Gong, et al.
Nature Genetics (2024)
Closed Access | Times Cited: 5
CRLF1 and CLCF1 in Development, Health and Disease
Laura Crisponi, Insa Buers, Frank Rutsch
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 2, pp. 992-992
Open Access | Times Cited: 23
CLCF1 inhibits energy expenditure via suppressing brown fat thermogenesis
Youwen Yuan, Kangli Li, Xueru Ye, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 3
Open Access | Times Cited: 3
Construction and validation of a TP53-associated immune prognostic model for gastric cancer
Kechao Nie, Zhihua Zheng, Yi Wen, et al.
Genomics (2020) Vol. 112, Iss. 6, pp. 4788-4795
Closed Access | Times Cited: 29
IL-6 family cytokines in respiratory health and disease
Ruby Dawson, Brendan J. Jenkins, Mohamed I. Saad
Cytokine (2021) Vol. 143, pp. 155520-155520
Closed Access | Times Cited: 25
Identification of the Prognostic Signatures of Glioma With Different PTEN Status
Pei Zhang, Xinyi Meng, Liqun Liu, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 23
Interleukin-11: A Potential Biomarker and Molecular Therapeutic Target in Non-Small Cell Lung Cancer
Jason H. Leung, Benjamin Ng, Wei‐Wen Lim
Cells (2022) Vol. 11, Iss. 14, pp. 2257-2257
Open Access | Times Cited: 17
Isovalerylspiramycin I suppresses non-small cell lung carcinoma growth through ROS-mediated inhibition of PI3K/AKT signaling pathway
Zeyu Liu, Moli Huang, Yue Hong, et al.
International Journal of Biological Sciences (2022) Vol. 18, Iss. 9, pp. 3714-3730
Open Access | Times Cited: 16
An engineered ligand trap inhibits leukemia inhibitory factor as pancreatic cancer treatment strategy
Sean A. Yamada‐Hunter, Brianna J. McIntosh, Yu Shi, et al.
Communications Biology (2021) Vol. 4, Iss. 1
Open Access | Times Cited: 21
eIF3a sustains non-small cell lung cancer stem cell-like properties by promoting YY1-mediated transcriptional activation of β-catenin
Juyan Zheng, Tao Zhu, Wei Zhuo, et al.
Biochemical Pharmacology (2023) Vol. 213, pp. 115616-115616
Closed Access | Times Cited: 7
Engineering a potent receptor superagonist or antagonist from a novel IL-6 family cytokine ligand
Jun W. Kim, César Márquez, R. Andres Parra Sperberg, et al.
Proceedings of the National Academy of Sciences (2020) Vol. 117, Iss. 25, pp. 14110-14118
Open Access | Times Cited: 21
The Regulatory Role of RNA Metabolism Regulator TDP-43 in Human Cancer
Xueyou Ma, Yufan Ying, Haiyun Xie, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 17
CLCF1 Is a Novel Potential Immune-Related Target With Predictive Value for Prognosis and Immunotherapy Response in Glioma
Yuan Jiang, Qiankun Ji, Xiaoyan Long, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 12
Antigene MYCN Silencing by BGA002 Inhibits SCLC Progression Blocking mTOR Pathway and Overcomes Multidrug Resistance
Sonia Bortolotti, Silvia Angelucci, Luca Montemurro, et al.
Cancers (2023) Vol. 15, Iss. 3, pp. 990-990
Open Access | Times Cited: 6
Identification of a novel m5C/m6A-related gene signature for predicting prognosis and immunotherapy efficacy in lung adenocarcinoma
Yiming Ma, Jun Yang, Tiantai Ji, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 11
Protein Bait Hypothesis: circRNA-Encoded Proteins Competitively Inhibit Cognate Functional Isoforms
Huanqiang Zhao, Qiongjie Zhou, Xiaotian Li
Trends in Genetics (2021) Vol. 37, Iss. 7, pp. 616-624
Open Access | Times Cited: 15
COL11A1‐driven positive feedback loop modulates fibroblast transformation and activates pancreatic cancer progression
Defeng Sun, Tu Dai, Yuan Ji, et al.
Cell Biology International (2023) Vol. 47, Iss. 6, pp. 1081-1091
Closed Access | Times Cited: 5
Therapy-associated remodeling of pancreatic cancer revealed by single-cell spatial transcriptomics and optimal transport analysis
Carina Shiau, Jingyi Cao, Mark Gregory, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 5
High affinity modified ACE2 receptors protect from SARS-CoV-2 infection in hamsters
Yusuke Higuchi, Tatsuya Suzuki, Takao Arimori, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Closed Access | Times Cited: 14
Identification of the effects of COVID-19 on patients with pulmonary fibrosis and lung cancer: a bioinformatics analysis and literature review
Yang Li, Lipeng Niu
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top